Summary
Low-carb diets (about 100-130g of carbs a day) and ketogenic diets (under 20-30g a day) both lower blood sugar, but they work very differently in the body and have different long-term effects.
Low-carb eating tends to hold its glucose improvements over the long term, while keto diets often see glycaemic benefits fade along with adherence after the first several months.
Keto diets carry a higher risk of hypoglycaemia, reduced fiber and gut health, and unfavorable lipid changes (like higher LDL) in some people, especially those on insulin or sulfonylureas.
Current evidence favors moderate carbohydrate restriction as the first-line nutrition approach for type 2 diabetes, with keto reserved for short-term, medically supervised use only.
Introduction
Carbohydrates often get blamed for everything in Type 2 Diabetes from high sugars to weight gain to insulin resistance. Somewhere along the way, this has led to a common belief:
“If carbs are the problem, removing them completely must be the solution.”
This is where the confusion between low-carb and keto begins.
While both approaches reduce carbohydrate intake, they operate very differently at a metabolic level and their long-term effects on glucose control, gut health, lipid metabolism, and sustainability are far from the same.
Let’s break this down scientifically without fear, fad, or food guilt.
Definitions and Macronutrient Composition
Low-Carbohydrate Diet
A low-carbohydrate diet typically provides:
Carbohydrates: ~100–130 g/day (or 26–45% of total energy)
Protein: Moderate to high (20–30%)
Fat: Balanced, primarily unsaturated
This approach emphasizes carbohydrate quality rather than elimination, allowing inclusion of:
Whole grains (controlled portions)
Low-glycaemic fruits
Pulses and legumes
Non-starchy vegetables
Ketogenic Diet
A ketogenic diet is characterized by severe carbohydrate restriction:
Carbohydrates: <20–30 g/day (<5–10% of energy)
Fat: 70–80%
Protein: Moderate
The objective is to induce nutritional ketosis, defined by elevated circulating ketone bodies (β-hydroxybutyrate ≥0.5 mmol/L), shifting primary fuel utilization from glucose to fatty acids.
Metabolic Mechanisms
Low-Carbohydrate Diet: Metabolic Effects
Reduces postprandial glucose excursions
Lowers insulin demand
Improves hepatic and peripheral insulin sensitivity
Preserves endogenous glucose regulation
Supports incretin response through mixed macronutrient meals
Importantly, glucose availability is reduced without complete suppression of glycolytic pathways.
Ketogenic Diet: Metabolic Effects
Near-total depletion of hepatic glycogen
Increased fatty acid oxidation
Elevated ketogenesis
Suppression of insulin secretion
Increased glucagon-to-insulin ratio
While glycaemic values may improve initially, metabolic flexibility is significantly reduced.
Clinical Outcomes in Type 2 Diabetes
Glycaemic Control
Short-term findings (3–6 months):
Both low-carb and keto diets demonstrate reductions in HbA1c
Rapid glucose lowering seen with keto due to carbohydrate elimination
Long-term findings (≥12 months):
Low-carb diets maintain glycaemic improvements
Keto diets show declining adherence and partial glycaemic relapse
Multiple trials indicate that glycaemic durability is superior with moderate carbohydrate restriction.
Time in Range (TIR)
Low-carbohydrate diets:
Improve postprandial variability
Reduce glycaemic excursions
Support sustained TIR improvement
Ketogenic diets:
Reduce hyperglycaemia
Increase risk of hypoglycaemia, particularly in insulin or sulfonylurea users
Gut Microbiota and Fiber Considerations
Low-Carbohydrate Diet
Maintains fermentable fiber intake
Supports short-chain fatty acid (SCFA) production
Preserves microbial diversity
Enhances intestinal barrier integrity
Ketogenic Diet
Markedly reduced fiber intake
Decreased butyrate-producing bacteria
Increased risk of dysbiosis
Potential pro-inflammatory gut environment
Gut health impairment remains a major limitation of prolonged ketogenic diets.
Lipid Metabolism and Cardiovascular Risk
Low-carbohydrate diets typically:
Improve triglyceride levels
Increase HDL cholesterol
Maintain LDL stability when fats are unsaturated
Ketogenic diets may:
Elevate LDL-C in hyper-responders
Increase ApoB and small dense LDL
Worsen cardiovascular risk profile in susceptible individuals
This is clinically significant in T2DM populations with pre-existing cardiometabolic risk.
Hypoglycaemia Risk and Medication Interaction
Ketogenic diets significantly increase hypoglycaemia risk due to:
Reduced hepatic glucose output
Ongoing medication effects
Impaired counter-regulatory response
Low-carbohydrate diets allow:
Safer medication titration
Reduced glycaemic volatility
Lower incidence of severe hypoglycaemic events
Sustainability and Behavioral Adherence
Low-carbohydrate diets demonstrate:
Higher long-term adherence
Cultural adaptability (including Indian dietary patterns)
Lower relapse and weight regain rates
Ketogenic diets show:
High attrition rates
Social and psychological burden
Frequent rebound hyperglycaemia post discontinuation
Clinical Consensus and Practical Application
Current evidence supports:
Moderate carbohydrate restriction as a first-line nutritional strategy in T2DM
Ketogenic diets may be considered only:
Short term
Under medical supervision
With close glucose and medication monitoring
They are not recommended as a long-term dietary therapy for most individuals with Type 2 Diabetes.
Key Clinical Takeaway
Type 2 Diabetes management benefits more from:
Carbohydrate moderation rather than elimination
Fiber preservation
Metabolic flexibility
Sustainable behavioral adherence
Long-term glycaemic control is achieved not through metabolic extremes, but through structured, physiologically supportive nutrition strategies.
Final Note
Any dietary intervention in T2DM should be individualized, regularly reviewed, and integrated with pharmacotherapy, physical activity, and metabolic monitoring to ensure safety and durability of outcomes.
